EFEKTIVITAS PEMBERIAN JUS BUAH NAGA MERAH (Hylocereus polyrhizus) TERHADAP KADAR HEMOGLOBIN TENAGA MEDIS DI RUMAH SAKIT AMALIA MEDIKA PANGKALAN KERINCI
Main Article Content
Abstract
Anemia is a common problem that often occurs in developing countries including Indonesia, most anemia is caused by hemoglobin levels less than 11 g/dl. Hemoglobin is a complex protein that binds iron (Fe) and is present in erythrocytes. Low hemoglobin levels are caused by iron deficiency, folic acid deficiency and chronic disease. The increase in hemoglobin levels with iron and vitamin C can be higher than with iron alone. Red dragon fruit (Hylocereus polyrhizus) has long been consumed by the public as a medicine to increase blood. This fruit contains organic acids, protein, minerals such as potassium, magnesium, calcium and iron as well as vitamin C. This study aims to determine the effectivity of giving red dragon fruit juice (Hylocereus polyrhizus) on hemoglobin levels in medical personnel at Amalia Medika Hospital Pangkalan Kerinci. This study used a pre-experimental method with a one group pretest-posttest design, in which hemoglobin levels were measured before giving red dragon fruit juice and after the respondent was given red dragon fruit juice 4 times in 30 days. The results showed that there was a significant difference between hemoglobin levels before and after administration of red dragon fruit juice with p=0.000 (α=0.05) in the paired sample t test. This means that there is an effect of giving dragon fruit juice on the hemoglobin level of medical staff at Amalia Medika Hospital in Pangkalan Kerinci, namely an increase in hemoglobin levels after being given dragon fruit juice of 2.61 g/dL to the respondent.
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the journal, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- That its publication has been approved by all the author(s) and by the responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.